BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35546696)

  • 21. Preoperative plasma D-dimer levels predict survival in patients with operable non-small cell lung cancer independently of venous thromboembolism.
    Zhang PP; Sun JW; Wang XY; Liu XM; Li K
    Eur J Surg Oncol; 2013 Sep; 39(9):951-6. PubMed ID: 23810331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COPD may increase the incidence of refractory supraventricular arrhythmias following pulmonary resection for non-small cell lung cancer.
    Sekine Y; Kesler KA; Behnia M; Brooks-Brunn J; Sekine E; Brown JW
    Chest; 2001 Dec; 120(6):1783-90. PubMed ID: 11742902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic obstructive pulmonary disease and comorbidities' influence on mortality in non-small cell lung cancer patients.
    Media AS; Persson M; Tajhizi N; Weinreich UM
    Acta Oncol; 2019 Aug; 58(8):1102-1106. PubMed ID: 31092081
    [No Abstract]   [Full Text] [Related]  

  • 24. Marginal pulmonary function should not preclude lobectomy in selected patients with non-small cell lung cancer.
    Taylor MD; LaPar DJ; Isbell JM; Kozower BD; Lau CL; Jones DR
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):738-44; Discussion 744-6. PubMed ID: 24252944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for postoperative complications and long-term survival in elderly lung cancer patients: a single institutional experience in Turkey.
    Sezen CB; Gokce A; Kalafat CE; Aker C; Tastepe AI
    Gen Thorac Cardiovasc Surg; 2019 May; 67(5):442-449. PubMed ID: 30421384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Study of Complete Video-Assisted Thoracoscopic Surgery Lobectomy in Treatment of Elderly Patients with Non-Small Cell Lung Cancer: Curative Effect and Impact on Clinical Prognosis.
    Xue Y; Wang YY; Zhang K; Cong W; He B; Zeng FC
    Cell Biochem Biophys; 2015 Nov; 73(2):399-404. PubMed ID: 27352329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness analysis of stereotactic body radiotherapy and surgery for medically operable early stage non small cell lung cancer.
    Paix A; Noel G; Falcoz PE; Levy P
    Radiother Oncol; 2018 Sep; 128(3):534-540. PubMed ID: 29706462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimizing Survival of Patients With Marginally Operable Stage IIIA Non-Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery.
    Yang KL; Chang YC; Ko HL; Chi MS; Wang HE; Hsu PS; Lin CC; Yeh DY; Kao SJ; Jiang JS; Chi KH
    Clin Lung Cancer; 2016 Nov; 17(6):550-557. PubMed ID: 27378175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of prehabilitation on ventilatory efficiency in non-small cell lung cancer patients: A cohort study.
    Gravier FE; Bonnevie T; Boujibar F; Médrinal C; Prieur G; Combret Y; Muir JF; Cuvelier A; Baste JM; Debeaumont D
    J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2504-2512.e1. PubMed ID: 30982587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of the epidermal growth factor receptor mutation status on the post-recurrence survival of patients with surgically resected non-small-cell lung cancer.
    Takenaka T; Takenoyama M; Yamaguchi M; Toyozawa R; Inamasu E; Kojo M; Toyokawa G; Yoshida T; Shiraishi Y; Morodomi Y; Hirai F; Taguchi K; Shimokawa M; Seto T; Ichinose Y
    Eur J Cardiothorac Surg; 2015 Mar; 47(3):550-5. PubMed ID: 24894095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical Outcomes after Pulmonary Resection for Non-Small Cell Lung Cancer with Localized Pleural Seeding First Detected during Surgery.
    Yun JK; Kim MA; Choi CM; Choi SH; Kim YH; Kim DK; Park SI; Kim HR
    Thorac Cardiovasc Surg; 2018 Mar; 66(2):142-149. PubMed ID: 26669768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Value of surgery for stage IIIa non-small cell lung cancer].
    Liu H; Wang M; Hu K; Xu Y; Ma M; Zhong W; Zhao J; Li L; Wang H
    Zhongguo Fei Ai Za Zhi; 2013 Dec; 16(12):639-45. PubMed ID: 24345488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of preoperative body mass index on respiratory complications after pneumonectomy for non-small-cell lung cancer. Results from a series of 154 consecutive standard pneumonectomies.
    Petrella F; Radice D; Borri A; Galetta D; Gasparri R; Solli P; Veronesi G; Spaggiari L
    Eur J Cardiothorac Surg; 2011 May; 39(5):738-44. PubMed ID: 20952203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of Smoking Cessation on Surgical Outcome in Primary Lung Cancer.
    Fukui M; Suzuki K; Matsunaga T; Oh S; Takamochi K
    Ann Thorac Surg; 2019 Apr; 107(4):1005-1009. PubMed ID: 30610851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary fibrosis and lung cancer: risk and benefit analysis of pulmonary resection.
    Kumar P; Goldstraw P; Yamada K; Nicholson AG; Wells AU; Hansell DM; Dubois RM; Ladas G
    J Thorac Cardiovasc Surg; 2003 Jun; 125(6):1321-7. PubMed ID: 12830051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: impact on survival and acute exacerbation.
    Moon SW; Park MS; Kim YS; Jang J; Lee JH; Lee CT; Chung JH; Shim HS; Lee KW; Kim SS; Lee SH; Yoon HI
    BMC Pulm Med; 2019 Oct; 19(1):177. PubMed ID: 31615505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of preoperative smoking status on postoperative complication rates and pulmonary function test results 1-year following pulmonary resection for non-small cell lung cancer.
    Groth SS; Whitson BA; Kuskowski MA; Holmstrom AM; Rubins JB; Kelly RF
    Lung Cancer; 2009 Jun; 64(3):352-7. PubMed ID: 19019489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lobectomy for Non-Small Cell Lung Cancer by Video-Assisted Thoracic Surgery: Effects of Cumulative Institutional Experience on Adequacy of Lymphadenectomy.
    Lee PC; Kamel M; Nasar A; Ghaly G; Port JL; Paul S; Stiles BM; Andrews WG; Altorki NK
    Ann Thorac Surg; 2016 Mar; 101(3):1116-22. PubMed ID: 26654728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical therapeutic strategy for non-small cell lung cancer with mediastinal lymph node metastasis (N2).
    Ma Q; Liu D; Guo Y; Shi B; Song Z; Tian Y
    Zhongguo Fei Ai Za Zhi; 2010 Apr; 13(4):342-8. PubMed ID: 20677562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative pulmonary function as a prognostic factor for stage I non-small cell lung carcinoma.
    Iizasa T; Suzuki M; Yasufuku K; Iyoda A; Otsuji M; Yoshida S; Sekine Y; Shibuya K; Saitoh Y; Hiroshima K; Fujisawa T
    Ann Thorac Surg; 2004 Jun; 77(6):1896-902; discussion 1902-3. PubMed ID: 15172232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.